ARTICLE | Clinical News
Lambda: Phase II started
October 24, 2016 7:00 AM UTC
Eiger began the open-label, international Phase II LIMT HDV trial to evaluate 120 and 180 ug subcutaneous Lambda once weekly for 48 weeks in about 30 patients. Eiger has worldwide rights to Lambda fro...